TipRanks
Sorrento Therapeutics (SRNE)
OTHER OTC:SRNE
US Market
SRNE
Sorrento Therapeutics
RESEARCH TOOLSreports

Sorrento Therapeutics (SRNE) Balance Sheet

5,214 Followers

Sorrento Therapeutics Balance Sheet

Sorrento Therapeutics's total assets for Q2 2023 were $456.69M, a decrease of -0.73% from the previous quarter. SRNE total liabilities were $654.65M for the fiscal quarter, a 11.43% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 472.84M$ 694.82M$ 535.82M$ 557.63M$ 674.73M
Total Liabilities
$ 494.51M$ 616.69M$ 395.09M$ 524.88M$ 467.23M
Total Equity Gross Minority
$ -21.67M$ 78.13M$ 140.73M$ 32.76M$ 207.50M
Other Metrics
Currency in USD

Sorrento Therapeutics Debt to Assets